Intradermal acupuncture in the treatment of rheumatoid arthritis with liver and kidney deficiency syndrome – A sham-controlled, randomized, clinical trial

Background and purpose: Rheumatoid arthritis (RA) is called “immortal cancer”, and it affects the quality of life, disability rate and even the survival of patients. This study aimed to observe the clinical efficacy, and adverse reactions of intradermal acupuncture (IA) in the treatment of RA patien...

Full description

Bibliographic Details
Main Authors: Huifang Luo, Ping Du, Wenyan Qin, Yiyi Hu, Zhen Xian, Changsong Lin, Peiwu Li, Yang Song, Xiangwei Yang
Format: Article
Language:English
Published: Elsevier 2024-06-01
Series:Complementary Therapies in Medicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0965229924000256
_version_ 1797214910427430912
author Huifang Luo
Ping Du
Wenyan Qin
Yiyi Hu
Zhen Xian
Changsong Lin
Peiwu Li
Yang Song
Xiangwei Yang
author_facet Huifang Luo
Ping Du
Wenyan Qin
Yiyi Hu
Zhen Xian
Changsong Lin
Peiwu Li
Yang Song
Xiangwei Yang
author_sort Huifang Luo
collection DOAJ
description Background and purpose: Rheumatoid arthritis (RA) is called “immortal cancer”, and it affects the quality of life, disability rate and even the survival of patients. This study aimed to observe the clinical efficacy, and adverse reactions of intradermal acupuncture (IA) in the treatment of RA patients with liver and kidney deficiency syndrome. Materials and methods: 132 RA patients were split into an IA group and a sham IA group at a 1:1 ratio. Both groups were assessed before and after the intervention with the assessments: a traditional Chinese medicine (TCM) syndrome evaluation, the Health Assessment Questionnaire (HAQ), the Disease Activity Score 28 (DAS28) and serum C-reactive protein (CRP). Results: There was a statistically significant difference in TCM syndrome evaluation, HAQ, DAS28, and CRP between both groups before and after treatment (P < 0.01). The improvement of TCM syndrome evaluation (95% CI [1.14(0.38–1.89)]; P = 0.001), HAQ (95% CI [2.00(1.00–3.00)]; P = 0.003), and DAS28 (95% CI [0.11(0.02–0.20)]; P = 0.021) in the IA group was more obvious than that in the sham IA group (P < 0.05), except for CRP (95% CI [0.50(− 2.09 to 7.08)], P = 0.786). The difference in CRP outcome changes between the two groups was not statistically significant (P > 0.05). Both groups had comparable results in the implementation of RA in the upper and lower extremity acupoints and did not differ due to different sites (IA group: P = 0.852; sham IA group: P = 0.861). The comparison of effective rate of the upper limb as well as that of the lower limb was statistically significant (P = 0.001). Besides, patients reported no adverse effects. Conclusion: The IA intervention was associated with a promising effect on the decrease in RA disease activity and delayed overall disease progression.
first_indexed 2024-04-24T11:21:41Z
format Article
id doaj.art-a2f611978f004c77a8dded77154975c9
institution Directory Open Access Journal
issn 0965-2299
language English
last_indexed 2024-04-24T11:21:41Z
publishDate 2024-06-01
publisher Elsevier
record_format Article
series Complementary Therapies in Medicine
spelling doaj.art-a2f611978f004c77a8dded77154975c92024-04-11T04:40:51ZengElsevierComplementary Therapies in Medicine0965-22992024-06-0182103037Intradermal acupuncture in the treatment of rheumatoid arthritis with liver and kidney deficiency syndrome – A sham-controlled, randomized, clinical trialHuifang Luo0Ping Du1Wenyan Qin2Yiyi Hu3Zhen Xian4Changsong Lin5Peiwu Li6Yang Song7Xiangwei Yang8School of Nursing, Shantou University Medical College, Shantou, Guangdong, ChinaSchool of Nursing, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, ChinaSchool of Nursing, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, ChinaGuangzhou University of Traditional Chinese Medicine First Affiliated Hospital, Guangzhou, Guangdong, ChinaGuangzhou University of Traditional Chinese Medicine First Affiliated Hospital, Guangzhou, Guangdong, ChinaGuangzhou University of Traditional Chinese Medicine First Affiliated Hospital, Guangzhou, Guangdong, ChinaGuangzhou University of Traditional Chinese Medicine First Affiliated Hospital, Guangzhou, Guangdong, ChinaSchool of Nursing, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China; Correspondence to: School of Nursing, Guangzhou University of Chinese Medicine, Guangzhou, China.Guangzhou University of Traditional Chinese Medicine First Affiliated Hospital, Guangzhou, Guangdong, China; Correspondence to: Department of Rheumatology, Guangzhou University of Traditional Chinese Medicine First Affiliated Hospital, Guangzhou, Guangdong, China.Background and purpose: Rheumatoid arthritis (RA) is called “immortal cancer”, and it affects the quality of life, disability rate and even the survival of patients. This study aimed to observe the clinical efficacy, and adverse reactions of intradermal acupuncture (IA) in the treatment of RA patients with liver and kidney deficiency syndrome. Materials and methods: 132 RA patients were split into an IA group and a sham IA group at a 1:1 ratio. Both groups were assessed before and after the intervention with the assessments: a traditional Chinese medicine (TCM) syndrome evaluation, the Health Assessment Questionnaire (HAQ), the Disease Activity Score 28 (DAS28) and serum C-reactive protein (CRP). Results: There was a statistically significant difference in TCM syndrome evaluation, HAQ, DAS28, and CRP between both groups before and after treatment (P < 0.01). The improvement of TCM syndrome evaluation (95% CI [1.14(0.38–1.89)]; P = 0.001), HAQ (95% CI [2.00(1.00–3.00)]; P = 0.003), and DAS28 (95% CI [0.11(0.02–0.20)]; P = 0.021) in the IA group was more obvious than that in the sham IA group (P < 0.05), except for CRP (95% CI [0.50(− 2.09 to 7.08)], P = 0.786). The difference in CRP outcome changes between the two groups was not statistically significant (P > 0.05). Both groups had comparable results in the implementation of RA in the upper and lower extremity acupoints and did not differ due to different sites (IA group: P = 0.852; sham IA group: P = 0.861). The comparison of effective rate of the upper limb as well as that of the lower limb was statistically significant (P = 0.001). Besides, patients reported no adverse effects. Conclusion: The IA intervention was associated with a promising effect on the decrease in RA disease activity and delayed overall disease progression.http://www.sciencedirect.com/science/article/pii/S0965229924000256Intradermal acupunctureRheumatoid arthritisLiver and kidney deficiency syndromeClinical trial
spellingShingle Huifang Luo
Ping Du
Wenyan Qin
Yiyi Hu
Zhen Xian
Changsong Lin
Peiwu Li
Yang Song
Xiangwei Yang
Intradermal acupuncture in the treatment of rheumatoid arthritis with liver and kidney deficiency syndrome – A sham-controlled, randomized, clinical trial
Complementary Therapies in Medicine
Intradermal acupuncture
Rheumatoid arthritis
Liver and kidney deficiency syndrome
Clinical trial
title Intradermal acupuncture in the treatment of rheumatoid arthritis with liver and kidney deficiency syndrome – A sham-controlled, randomized, clinical trial
title_full Intradermal acupuncture in the treatment of rheumatoid arthritis with liver and kidney deficiency syndrome – A sham-controlled, randomized, clinical trial
title_fullStr Intradermal acupuncture in the treatment of rheumatoid arthritis with liver and kidney deficiency syndrome – A sham-controlled, randomized, clinical trial
title_full_unstemmed Intradermal acupuncture in the treatment of rheumatoid arthritis with liver and kidney deficiency syndrome – A sham-controlled, randomized, clinical trial
title_short Intradermal acupuncture in the treatment of rheumatoid arthritis with liver and kidney deficiency syndrome – A sham-controlled, randomized, clinical trial
title_sort intradermal acupuncture in the treatment of rheumatoid arthritis with liver and kidney deficiency syndrome a sham controlled randomized clinical trial
topic Intradermal acupuncture
Rheumatoid arthritis
Liver and kidney deficiency syndrome
Clinical trial
url http://www.sciencedirect.com/science/article/pii/S0965229924000256
work_keys_str_mv AT huifangluo intradermalacupunctureinthetreatmentofrheumatoidarthritiswithliverandkidneydeficiencysyndromeashamcontrolledrandomizedclinicaltrial
AT pingdu intradermalacupunctureinthetreatmentofrheumatoidarthritiswithliverandkidneydeficiencysyndromeashamcontrolledrandomizedclinicaltrial
AT wenyanqin intradermalacupunctureinthetreatmentofrheumatoidarthritiswithliverandkidneydeficiencysyndromeashamcontrolledrandomizedclinicaltrial
AT yiyihu intradermalacupunctureinthetreatmentofrheumatoidarthritiswithliverandkidneydeficiencysyndromeashamcontrolledrandomizedclinicaltrial
AT zhenxian intradermalacupunctureinthetreatmentofrheumatoidarthritiswithliverandkidneydeficiencysyndromeashamcontrolledrandomizedclinicaltrial
AT changsonglin intradermalacupunctureinthetreatmentofrheumatoidarthritiswithliverandkidneydeficiencysyndromeashamcontrolledrandomizedclinicaltrial
AT peiwuli intradermalacupunctureinthetreatmentofrheumatoidarthritiswithliverandkidneydeficiencysyndromeashamcontrolledrandomizedclinicaltrial
AT yangsong intradermalacupunctureinthetreatmentofrheumatoidarthritiswithliverandkidneydeficiencysyndromeashamcontrolledrandomizedclinicaltrial
AT xiangweiyang intradermalacupunctureinthetreatmentofrheumatoidarthritiswithliverandkidneydeficiencysyndromeashamcontrolledrandomizedclinicaltrial